The Adam Alabata Sanborn
Rare Gastrointestinal Cancers Program at ICAN
Adam Alabata Sanborn
In Loving Memory
The Adam Alabata Sanborn Rare Gastrointestinal Cancers Program at ICAN
is a vital part of ICAN's Cancer Patient Advocacy and Clinical Trials Advocacy Programs.
For more information, please email Adam.Sanborn.Program@askican.org
To support this program, please click below or scan the qr code.
About ICAN
Mission
ICAN's mission is to assist and empower late-stage patients worldwide with cutting-edge information regarding anticancer drugs in clinical trials as well as physician referrals at the patient’s request based on the patient’s reported medical situation. ICAN takes the position that there are key decision points in the battle for life and with the best available information, the cancer patient will be well-armed for the road ahead.
What people are saying:
Federal Tax I.D.: EIN 86-0818253